Molecular Characterization of Measles and Rubella Virus Strains from the 2018-2019 Epidemic in Madagascar. [PDF]
Razafindratsimandresy R +9 more
europepmc +1 more source
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis. [PDF]
Ingvarsson J +12 more
europepmc +1 more source
Letter to the Editor: Bridging the immunization gap in pediatric autoimmune disorders - insights from inflammatory bowel disease and vaccine response patterns. [PDF]
Al-Hussaniy HA.
europepmc +1 more source
Genetically predicted anti‑rubella virus IgG levels and dermatitis risk: A two‑sample Mendelian randomization study. [PDF]
Ouyang Z +5 more
europepmc +1 more source
Seroprotection to five vaccine-preventable diseases among children in East New Britain, Papua New Guinea. [PDF]
Vaccher S +13 more
europepmc +1 more source
Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. [PDF]
Chun JY +9 more
europepmc +1 more source
Safe seroconversion after receiving measles, mumps, and rubella live vaccine during guselkumab treatment for psoriasis. [PDF]
Kim K, Kirshen C.
europepmc +1 more source
Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025. [PDF]
Pan X +5 more
europepmc +1 more source
Notes from the Field: Congenital Rubella Syndrome - Florida, 2025. [PDF]
Alak M +6 more
europepmc +1 more source

